Drugs that contain Mecasermin Recombinant

1. Increlex patent expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US6207640 IPSEN INC Treatment of partial growth hormone insensitivity syndrome
Apr, 2014

(10 years ago)

US5824642 IPSEN INC Treatment of partial growth hormone insensitivity syndrome
Jul, 2014

(9 years ago)

US5681814 IPSEN INC Formulated IGF-I Composition
Sep, 2017

(6 years ago)




Drug Exclusivity Drug Exclusivity Expiration
Orphan Drug Exclusivity(ODE) Aug 30, 2012

Market Authorisation Date: 30 August, 2005

Treatment: Treatment of primary igf-1 deficiency

Dosage: INJECTABLE

More Information on Dosage

INCRELEX family patents

Family Patents